GHK-Cu

GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK), a naturally occurring human peptide with an affinity for copper(II) similar to that of the copper-transport site on albumin. GHK is present in human plasma and other tissues, and it readily forms the GHK-Cu chelate that carries out most of its biological activity ^[1].

First isolated from human plasma in the 1970s, GHK was identified through its ability to promote tissue remodeling and wound repair, and it became a foundation of copper-peptide skincare. Its serum concentration declines markedly with age, averaging roughly 200 nanograms per milliliter around age 20 and falling to about 80 nanograms per milliliter by age 60, which helped frame it as an anti-aging molecule ^[2].

Its research applications center on skin and connective-tissue regeneration. GHK-Cu chemoattracts repair cells, exerts anti-inflammatory and antioxidant effects, and increases synthesis of collagen, elastin, glycosaminoglycans, and a range of growth factors while supporting angiogenesis and nerve outgrowth ^[1]. Controlled studies on aged skin have reported tightening, improved elasticity and firmness, and reductions in fine lines, photodamage, and hyperpigmentation ^[1]. Newer gene-profiling work attributes its unusually broad, health-positive actions to the many biochemical pathways it appears to regulate ^[3], and formulation studies show it can synergize with other actives; combined with hyaluronic acid it raised collagen IV synthesis in skin-cell tests by as much as 25.4-fold ^[4].

GHK-Cu is widely available and generally sold as a cosmetic ingredient in topical anti-aging and skin-repair formulations, and as a research peptide; it is well tolerated, though long-term controlled data are still accumulating.

Applied topically, GHK-Cu is very well tolerated, with mild transient irritation the main complaint. Injected or systemic use is far less characterized and carries a theoretical risk of copper overload with excessive dosing; the strongest evidence remains cosmetic and topical.

The tripeptide GHK (glycyl-L-histidyl-L-lysine) was discovered by biochemist Loren Pickart in the early 1970s during doctoral research at the University of California, San Francisco. He identified GHK as a factor in human plasma that caused aged liver tissue to behave more like young tissue, and later established that its activity depends on its high affinity for copper(II), forming the GHK-Cu complex. Over the following decades the copper peptide was shown to stimulate collagen synthesis, wound healing, and tissue remodeling, leading to its widespread adoption in skincare and cosmetic formulations. Pickart's continued work, including a 2008 review on GHK and tissue remodeling, helped define the broad biochemical program the peptide activates.

GHK-Cu enjoys near-legendary status among cosmetic peptides, often called the original and still-reigning copper peptide for anti-aging skincare. It is prized because it prompts skin to rebuild itself, boosting collagen, elastin, and glycosaminoglycans rather than merely moisturizing the surface, and controlled studies on aged skin have shown it can firm skin and reduce wrinkles and photodamage. Users and formulators value its combination of visible results, gentle tolerability, and a wide antioxidant and protective profile. Its reputation rests on a substantial body of research, though real-world results depend heavily on formulation and delivery.